Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor
Pharmacological Research · 2026-11 · 109741
DOI: 10.1016/j.phrs.2026.109741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Research, 2026-11. Verfasst von Zhibi Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming 650500, China. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming 650500, China.
- Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cance…
- Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China.
- Yunnan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming 650500, China; Yunnan Key Laboratory of Breast Cancer Precision Medicine, The Third Affili…
- Yunnan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming 650500, China. Electronic address: zhanglonglong@kmmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z., Ta, M., Shi, L., Dai, X., Chen, Y., Pan, C., Zhang, Z., Chen, Y., Wang, C., Liu, W., Chen, C., & Zhang, L. (2026). Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor. Pharmacological Research, 109741. https://doi.org/10.1016/j.phrs.2026.109741
Vancouver
Zhang Z, Ta M, Shi L, Dai X, Chen Y, Pan C, et al. Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor. Pharmacological Research. 2026:109741. doi:10.1016/j.phrs.2026.109741
BibTeX
@article{Zhang2026,
author = {Zhang, Zhibi and Ta, Mengdie and Shi, Linyuan and Dai, Xueqin and Chen, Yajuan and Pan, Chenglong and Zhang, Ziyu and Chen, Yanping and Wang, Chunyan and Liu, Wen and Chen, Ceshi and Zhang, Longlong},
title = {Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor},
journal = {Pharmacological Research},
year = {2026},
pages = {109741},
doi = {10.1016/j.phrs.2026.109741}
}
EUVIMED